Artialis has over 10 years of experience in assay development and sample measurement throughout all phases of drug development. We are specialized in discovery, preclinical, and clinical research and will help you achieve your bioanalytical goals tailored to your needs. Many of our biomarkers are translational. They can be used in preclinical studies for the selection of modulated markers, which can then be used during the clinical phases of your drug development for efficacy evaluation or mode of action assessment.
We have over 40 validated biomarkers for the following therapeutic areas:
- Rheumatology and musculoskeletal disease
- Age-related disorders
- Cardiovascular diseases
- Gastrointestinal disorders
In addition to biomarkers, we also offer bioanalytical services using OMICs techniques, including genomics, transcriptomics, proteomics and metabolomics analyses, as well as flow cytometry.
We work hand in hand with you through every step of your project. Our dedicated ISO 9001 certified management system and transversal organization allow for reduced timelines, efficient communication, and a quick reaction time.
Being a contract research and development organization (CRDO), we are highly science-driven and pride ourselves on our academic and industry collaborations, as well as being part of regional and European research consortia.
Artialis’ biotesting services are detailed below by clicking on each icon.
For more information, contact the head of the biotesting department, Dr. Melanie Uebelhoer :